1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6211)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13088)
  2. Department of Medicine (13004)
  3. Center for Hematologic Malignancies (10395)
  4. GSK Faculty (4422)
  5. Adult Leukemia (3583)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (775)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (204)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (431)

More Publishers

Results (13088)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Plasmacytoid dendritic cell proportion is predictive of risk and outcomes in myelodysplastic syndromes
    Meeting Abstract

    Chan, A.; Zhang, Y.; Devlin, S. M.; Lewis, N.; Baik, J.; Arcila, M. E.; Klimek, V. M.; Roshal, M.; Xiao, W.
    Blood (2019)

    Fulltext@MSK | Save
  • Potent synergy between combination of chimeric antigen receptor (CAR) therapy targeting CD19 in conjunction with dendritic cell (DC)/tumor fusion vaccine in hematological malignancies
    Meeting Abstract

    Capelletti, M.; Liegel, J.; Themeli, M.; Mutis, T.; Stroopinsky, D.; Orr, S.; Torres, D.; Morin, A.; Gunset, G.; Ghiasuddin, H.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Newly diagnosed AML patient samples demonstrate high degree of concordance in identification of pathogenic mutations by next generation sequencing (NGS) performed at enrolling institutions compared to central laboratory results in the Beat AML Master Trial
    Meeting Abstract

    Borate, U.; Ruppert, A. S.; Yang, F.; Jones, D.; Caruthers, S.; Zhao, W.; Vergilio, J. A.; Burd, A.; Pavlick, D.; Juckett, L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Targeted sequencing predicts the development of myeloid malignancies and clinical outcome in patients with unexplained cytopenia
    Meeting Abstract

    Cargo, C.; Bolton, K.; Beinortas, T.; Glover, P.; Short, M.; Smith, A.; Taylor, J.; Evans, P. A. S.; Papaemmanuil, E.; Crouch, S.
    Blood (2019)

    Fulltext@MSK | Save
  • Time to second treatment as a proxy for overall survival in CLL/SLL: Identifying risk factors to help guide treatment selection
    Meeting Abstract

    Bantilan, K. S.; Soumerai, J. D.; Roeker, L. E.; Mato, A. R.; Zelenetz, A. D.
    Blood (2019)

    Fulltext@MSK | Save
  • Brentuximab vedotin with chemotherapy for Stage 3/4 classical Hodgkin lymphoma (cHL): 4-year update of the ECHELON-1 study
    Meeting Abstract

    Bartlett, N. L.; Straus, D. J.; Dlugosz-Danecka, M.; Alekseev, S.; Illes, A.; Lech-Maranda, E.; Feldman, T. A.; Smolewski, P.; Savage, K. J.; Walewski, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • The blood microbiome predicts acute graft-versus-host disease after stem cell transplantation
    Meeting Abstract

    Blair, L.; Peled, J. U.; Giardina, P. A.; Slingerland, J. B.; Slingerland, A. E.; Hollemon, D.; Ho, C.; Bercovici, S.; Ahmed, A.; Hong, D. K.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era
    Meeting Abstract

    Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Genomic landscape of sex disparities in multiple myeloma
    Meeting Abstract

    Bal, S.; Choi, K.; Jamy, O.; Girnius, S. K.; Landau, H. J.; Costa, L. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Outpatient treatment with lisocabtagene maraleucel (liso-cel) in three ongoing clinical studies in relapsed/refractory (R/R) B cell non-Hodgkin lymphoma (NHL), including second-line transplant ineligible patients: TRANSCEND NHL 001, OUTREACH, and PILOT
    Meeting Abstract

    Bachier, C. R.; Palomba, M. L.; Abramson, J. S.; Andreadis, C.; Sehgal, A. R.; Godwin, J.; Hildebrandt, G. C.; Siddiqi, T.; Stevens, D.; Farazi, T.; more...
    Blood (2019)

    Fulltext@MSK | Save